Clinical Trial: Phase 3 Single Arm, Open Study on vYF in Adults

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222059) titled 'Phase 3 Single Arm, Open Study on vYF in Adults' on Oct. 27.

Brief Summary: The purpose of this study is to assess the safety and immunogenicity of vYF in adults aged 18 years and over in Japan.

Study details include:

* The study duration will be up to approximately 1 month.

* One single dose of vYF will be administrated subcutaneously at the 1st visit.

* The visit frequency will be Day 01 (Visit 01) and Day 29 (Visit 02). One telephone call (TC) will be planned at Day 15.

Number of Participants:

A total of 254 participants is expected to be included in the study with the aim to obtain a total of 203 evaluable participants.

S...